After the first generic enters the market, prices crash - but the real battle is just beginning. Learn how competitors enter, why authorized generics hurt first entrants, and how PBMs and patent tactics shape the future of generic drug pricing.
Learn More
The FDA's Abbreviated New Drug Application (ANDA) process lets generic drugmakers get approval without repeating full clinical trials. It's how 90% of U.S. prescriptions are filled at a fraction of the cost, saving billions annually.
Learn More